Lifecore Biomedical

company

About

Lifecore Biomedical is dedicated to the development of technically advanced hyaluronan based products.

  • 5001 - 10000

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$5M
Industries
Biotechnology,Manufacturing
Founded date
Jan 1, 1986
Number Of Employee
5001 - 10000
Operating Status
Active

Lifecore Biomedical is dedicated to the development of technically advanced hyaluronan based products that offer long-term compatibility with the human body.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$5M
Lifecore Biomedical has raised a total of $5M in funding over 2 rounds. Their latest funding was raised on Nov 25, 2022 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 25, 2022 Post-IPO Equity $5M 1 Wynnefield Capital Advisors Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Lifecore Biomedical is funded by 1 investors. Wynnefield Capital Advisors are the most recent investors.
Investor Name Lead Investor Funding Round
Wynnefield Capital Advisors Yes Post-IPO Equity